ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 149 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2016. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $69,000 | -97.7% | 12,307 | -97.8% | 0.00% | -97.9% |
| Q2 2016 | $3,028,000 | -26.2% | 551,521 | -0.2% | 0.15% | -27.0% |
| Q1 2016 | $4,101,000 | -14.7% | 552,751 | -4.5% | 0.20% | -11.9% |
| Q4 2015 | $4,810,000 | +8.1% | 578,805 | +17.2% | 0.23% | -2.2% |
| Q3 2015 | $4,451,000 | -26.2% | 493,966 | -1.8% | 0.23% | -19.4% |
| Q2 2015 | $6,033,000 | +79.3% | 502,770 | +37.8% | 0.29% | +70.4% |
| Q1 2015 | $3,364,000 | +151.8% | 364,808 | +38.4% | 0.17% | +138.0% |
| Q4 2014 | $1,336,000 | +18985.7% | 263,508 | +14872.0% | 0.07% | – |
| Q2 2014 | $7,000 | – | 1,760 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 15,151,516 | $38,182,000 | 7.99% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 10,406,850 | $26,225,000 | 4.02% |
| MILLER VALUE PARTNERS, LLC | 12,385,586 | $31,211,000 | 1.12% |
| CHIRON CAPITAL MANAGEMENT, LLC | 201,470 | $508,000 | 0.41% |
| Sargent Investment Group, LLC | 289,025 | $728,000 | 0.26% |
| MAGNOLIA CAPITAL ADVISORS LLC | 80,542 | $404,000 | 0.16% |
| XTX MARKETS LLC | 11,086 | $28,000 | 0.14% |
| Virtus ETF Advisers LLC | 99,108 | $250,000 | 0.13% |
| Old West Investment Management, LLC | 210,226 | $529,000 | 0.12% |
| EQUITEC PROPRIETARY MARKETS, LLC | 31,300 | $79,000 | 0.06% |